On April 22, 2026, Madrigal Pharmaceuticals reclassified two board members, Julian C. Baker and Daniel J. Brennan, from Class III and Class II to Class I to achieve more equal membership among the board's classes, effective for the upcoming Annual Meeting on June 17, 2026.